Advertisement

Clinical Scenario: Unexpected Positive Nodes at Radical Cystectomy

63-year-old man at radical cystectomy for T2 tumor has unexpected grossly positive lymph nodes
  • Christian ThomasEmail author
  • Joachim W. Thüroff
Chapter

Abstract

Positive lymph nodes are found in 20–30 % of patients undergoing radical cystectomy for bladder cancer. Their presence is associated with poor survival in the majority. Super-extended lymph node dissection is recommended in the presence of positive lymph nodes to possibly improve oncologic outcome. In patients with unsuspicious lymph nodes, dissection should be performed at least up to the common iliac vessels. Even in the presence of lymph node metastases cystectomy is indicated to reduce local tumor complications. The type of urinary diversion should not be altered by lymph node positivity unless the diversion would otherwise negatively influence the extent of the procedure.

Keywords

Bladder cancer Cystectomy Positive nodes Lymphadenetomy Preoperative imaging 

References

  1. 1.
    Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.PubMedGoogle Scholar
  2. 2.
    Morgan TM, Kaffenberger SD, Cookson MS. Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol. 2012;188:1081–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Steven K, Poulson AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol. 2007;178:1218–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Leissner J, Ghoneim MA, Abol-Enein H, Thüroff JW, Franzaring L, Fisch M, Schulze H, Managadze G, Allhoff EP, El-Baz MA, Kastendieck H, Buhtz P, Kropf S, Hohenfellern R, Wolf HK. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171:139–44.PubMedCrossRefGoogle Scholar
  5. 5.
    Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thüroff JW. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int. 2009;104:331–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DE, Stephenson AJ. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. J Urol. 2011;186:1269–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D. Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol. 2012;30:827–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology. 2013;263:326–42.CrossRefGoogle Scholar
  9. 9.
    Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol. 2009;55:761–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol. 2007;51:137–49.PubMedCrossRefGoogle Scholar
  11. 11.
    Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int. 2011;107:898–904.PubMedCrossRefGoogle Scholar
  12. 12.
    Leissner J, Hohenfellner R, Thüroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int. 2000;85:817–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Konety BR, Joslyn SA, O’Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol. 2003;169:946–50.PubMedCrossRefGoogle Scholar
  14. 14.
    May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol. 2011;18:2018–25.PubMedCrossRefGoogle Scholar
  15. 15.
    Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008;112:2401–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Fleischmann A, Thalmann GN, Narkwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23:2358–65.PubMedCrossRefGoogle Scholar
  17. 17.
    Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170:35–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol. 2011;60:946–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Int J Urol. 2009;16:274–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Urh A, Soliman PT, Schmeler KM, Estin S, Frumovitz M, Nick AM, Fellman B, Urbauer DL, Ramirez PT. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013;129:580–5.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of UrologyUniversity Medical Center, Johannes Gutenberg UniversityMainzGermany

Personalised recommendations